MNHA2_STAA1
ID MNHA2_STAA1 Reviewed; 800 AA.
AC A7WZ76;
DT 05-MAY-2009, integrated into UniProtKB/Swiss-Prot.
DT 23-OCT-2007, sequence version 1.
DT 25-MAY-2022, entry version 72.
DE RecName: Full=Putative antiporter subunit mnhA2;
DE AltName: Full=Mrp complex subunit A2;
DE AltName: Full=Putative NADH-ubiquinone oxidoreductase subunit mnhA2;
GN Name=mnhA2; Synonyms=mrpA2; OrderedLocusNames=SAHV_0619;
OS Staphylococcus aureus (strain Mu3 / ATCC 700698).
OC Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC Staphylococcus.
OX NCBI_TaxID=418127;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Mu3 / ATCC 700698;
RX PubMed=17954695; DOI=10.1128/aac.00534-07;
RA Neoh H.-M., Cui L., Yuzawa H., Takeuchi F., Matsuo M., Hiramatsu K.;
RT "Mutated response regulator graR is responsible for phenotypic conversion
RT of Staphylococcus aureus from heterogeneous vancomycin-intermediate
RT resistance to vancomycin-intermediate resistance.";
RL Antimicrob. Agents Chemother. 52:45-53(2008).
CC -!- SUBUNIT: May form a heterooligomeric complex that consists of seven
CC subunits: mnhA2, mnhB2, mnhC2, mnhD2, mnhE2, mnhF2 and mnhG2.
CC {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC protein {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the CPA3 antiporters (TC 2.A.63) subunit A
CC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AP009324; BAF77502.1; -; Genomic_DNA.
DR RefSeq; WP_000060771.1; NC_009782.1.
DR AlphaFoldDB; A7WZ76; -.
DR SMR; A7WZ76; -.
DR KEGG; saw:SAHV_0619; -.
DR HOGENOM; CLU_007100_2_1_9; -.
DR OMA; LSFTQFM; -.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR GO; GO:0015297; F:antiporter activity; IEA:UniProtKB-KW.
DR GO; GO:0006811; P:ion transport; IEA:UniProtKB-KW.
DR InterPro; IPR025383; MbhD-like_TM.
DR InterPro; IPR001750; ND/Mrp_mem.
DR InterPro; IPR001516; Proton_antipo_N.
DR Pfam; PF13244; DUF4040; 1.
DR Pfam; PF00361; Proton_antipo_M; 1.
DR Pfam; PF00662; Proton_antipo_N; 1.
PE 3: Inferred from homology;
KW Antiport; Cell membrane; Ion transport; Membrane; Transmembrane;
KW Transmembrane helix; Transport.
FT CHAIN 1..800
FT /note="Putative antiporter subunit mnhA2"
FT /id="PRO_0000372290"
FT TRANSMEM 1..21
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 33..53
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 78..98
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 118..138
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 167..187
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 207..227
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 241..261
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 273..293
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 300..320
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 331..351
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 387..407
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 424..444
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 472..492
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 527..547
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 595..615
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 627..647
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 651..671
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 676..696
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 712..732
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 768..788
FT /note="Helical"
FT /evidence="ECO:0000255"
SQ SEQUENCE 800 AA; 89610 MW; 1252897F1989D260 CRC64;
MSLVYLLIAI LVIMAMILLM SKRRALAKYA GYIALVAPVI SSIYFLIQIP SVAKLQYLST
SIPWIKTLDI NLDLRLDGLS LMFSLIISLI GIAVFFYATQ YLSSRKDNLP RFYFYLTLFM
FSMIGIVLSD NTILMYIFWE LTSVSSFLLI SYWYNNGDSQ FGAIQSFMIT VFGGLALLVG
FIMLYIMTGT NNITDILGQA DHIKNHGLFI PMIFMFLLGA FTKSAQFPFH IWLPRAMAAP
TPVSAYLHSA TMVKAGIFLL LRFTPLLGLS NMYIYIVTFV GLITMLFGSI TALKQWDLKG
ILAYSTISQL GMIMAMVGIG GGYAQHQQDA IASIYVFVLF GALFHLMNHA IFKCALFMGV
GILDHEAGSR DIRILSGMRQ LFPKMNLVMT IAALSMAGVP FLNGFLSKEM FLDALTQTGQ
LSQFSLISMI AIVFVGVIAS IFTFTYALYM VKEVFWTKYD SKVFTKKNIH EPWLFSLPSL
ILMVLVPVIF FVPNIFGKGI IVPALRGVSG GNHQIDPLAP HVSQWHGFNI PLLLTIIIIL
LGSVLAIKVD WKKVFTGKIR QISVSKGYEM VYRHFEKFAT KRFKRVMQDR LNQYIIMTLG
IFMIIIGYGY IRIGLPKVHQ LHVSEFGALE IILAIVTVTI GISLIFIRQR LTMVILNGVI
GFVVTLFFIA MKAPDLALTQ LVVETITTIL FIVSFSRLPN VPRSNANKKR EIIKISVSLL
MALIVVSLIF ITQQTDGLSS ISDFYLKADK LTGGKNIVNA ILGDFRALDT LFEGLVLIIT
GLGIYTLLNY QDRRGQDERE